Fukae S, Yamanaka K, Matsumura S, Tanaka R, Nakazawa S, Kakuta Y
IJU Case Rep. 2024; 7(6):423-426.
PMID: 39498178
PMC: 11531890.
DOI: 10.1002/iju5.12761.
Feng S, Chen T, Zhang Y, Lu C
Curr Issues Mol Biol. 2024; 46(9):10249-10258.
PMID: 39329962
PMC: 11431040.
DOI: 10.3390/cimb46090610.
Kim H, Cha H, Cheong T
Sci Rep. 2024; 14(1):20425.
PMID: 39227428
PMC: 11371817.
DOI: 10.1038/s41598-024-71322-5.
Yang S, Guan T, Yang H, Hu Y, Zhao Y
Front Med (Lausanne). 2024; 11:1349615.
PMID: 38523906
PMC: 10957742.
DOI: 10.3389/fmed.2024.1349615.
Paret K, Beyhaghi H, Herring W, Mauskopf J, Shane L, Rousculp M
Vaccines (Basel). 2024; 12(1).
PMID: 38250887
PMC: 10819070.
DOI: 10.3390/vaccines12010074.
Re-Emerging COVID-19: Controversy of Its Zoonotic Origin, Risks of Severity of Reinfection and Management.
Chala B, Tilaye T, Waktole G
Int J Gen Med. 2023; 16:4307-4319.
PMID: 37753439
PMC: 10518360.
DOI: 10.2147/IJGM.S419789.
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review.
Yihunie W, Nibret G, Aschale Y
Clin Pharmacol. 2023; 15:77-98.
PMID: 37554660
PMC: 10405914.
DOI: 10.2147/CPAA.S418314.
COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs.
Jiang M, Vaisanen E, Kolehmainen P, Huttunen M, Yla-Herttuala S, Meri S
Vaccine. 2023; 41(26):3813-3823.
PMID: 37142461
PMC: 10126225.
DOI: 10.1016/j.vaccine.2023.04.049.
COVID-19 vaccination and thyroiditis.
Sendur S, Oguz S, Unluturk U
Best Pract Res Clin Endocrinol Metab. 2023; 37(4):101759.
PMID: 36933997
PMC: 9981269.
DOI: 10.1016/j.beem.2023.101759.
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status.
Chavda V, Bezbaruah R, Valu D, Patel B, Kumar A, Prasad S
Vaccines (Basel). 2023; 11(2).
PMID: 36851309
PMC: 9965371.
DOI: 10.3390/vaccines11020432.
Using Rapid-Cycle Change to Improve COVID-19 Vaccination Strategy in Primary Care.
Hunt L, Sullivan E, Susa J, Chaufournier R, Joseph C, Phillips R
Int J Environ Res Public Health. 2023; 20(4).
PMID: 36833600
PMC: 9957472.
DOI: 10.3390/ijerph20042902.
Impact of Improper Storage of ChAdOx1-S (AstraZeneca) Vaccine on Its Efficacy and Safety.
Mikolajczyk M, Lewandowski R, Goncharuk A
Vaccines (Basel). 2023; 11(1).
PMID: 36679938
PMC: 9865338.
DOI: 10.3390/vaccines11010093.
Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2.
Chen X, Li H, Song H, Wang J, Zhang X, Han P
J Extracell Vesicles. 2022; 11(12):e12288.
PMID: 36450704
PMC: 9712136.
DOI: 10.1002/jev2.12288.
The Vaccine World of COVID-19: India's Contribution.
Chavda V, Vihol D, Solanki H, Apostolopoulos V
Vaccines (Basel). 2022; 10(11).
PMID: 36423038
PMC: 9695423.
DOI: 10.3390/vaccines10111943.
Therapeutic Strategies in the Fight against COVID-19: From Bench to Bedside.
Abadi B, Aarabi Jeshvaghani A, Fathalipour H, Dehghan L, Rahimi Sirjani K, Forootanfar H
Iran J Med Sci. 2022; 47(6):517-532.
PMID: 36380976
PMC: 9652495.
DOI: 10.30476/IJMS.2021.92662.2396.
A comprehensive review on variants of SARS-CoVs-2: Challenges, solutions and open issues.
Deepanshi , Budhiraja I, Garg D, Kumar N, Sharma R
Comput Commun. 2022; 197:34-51.
PMID: 36313592
PMC: 9598046.
DOI: 10.1016/j.comcom.2022.10.013.
Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis.
Li Z, Liu S, Li F, Li Y, Li Y, Peng P
Front Immunol. 2022; 13:965971.
PMID: 36177017
PMC: 9513208.
DOI: 10.3389/fimmu.2022.965971.
mRNA vaccines in the prevention and treatment of diseases.
Gu Y, Duan J, Yang N, Yang Y, Zhao X
MedComm (2020). 2022; 3(3):e167.
PMID: 36033422
PMC: 9409637.
DOI: 10.1002/mco2.167.
Voice Sequelae Following Recovery From COVID-19.
Romero Arias T, Betancort Montesinos M
J Voice. 2022; 39(1):287.e19-287.e25.
PMID: 35909049
PMC: 9250906.
DOI: 10.1016/j.jvoice.2022.06.033.
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants.
Bajoria S, Kaur K, Kumru O, Van Slyke G, Doering J, Novak H
Hum Vaccin Immunother. 2022; 18(5):2079346.
PMID: 35666264
PMC: 9621007.
DOI: 10.1080/21645515.2022.2079346.
